Diagnostics startup Droplet Biosciences partners with Nvidia to speed cancer test results

Diagnostics firm Droplet Biosciences said on Tuesday it is collaborating with Nvidia to use the chipmaker’s AI infrastructure to speed up post-surgery cancer test results.

The company has been using Nvidia Parabricks, a GPU-accelerated software suite, to drastically speed up genomic data ‌analysis for ⁠DNA sequencing.

⁠Droplet said its method can detect residual disease in 24 hours by analyzing lymphatic fluid collected post surgery, compared to the four to six weeks it typically takes for tumor remnants to appear in blood-based tests.